Finnegan Withdraws As Counsel In Hepatitis C Drug IP Row
A Delaware federal judge on Tuesday denied Gilead Sciences' motion to disqualify Finnegan Henderson Farabow Garrett & Dunner LLP from representing Idenix Pharmaceuticals Inc. as moot in a suit accusing Gilead...To view the full article, register now.
Already a subscriber? Click here to view full article